Overview

Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics and safety of single dose and multiple doses of desvenlafaxine in Korean healthy subjects and compare to westerners.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Desvenlafaxine Succinate